Montes Archimedes Acquisition (ROIV)
(Delayed Data from NSDQ)
$8.37 USD
-0.02 (-0.24%)
Updated Jan 26, 2023 04:00 PM ET
After-Market: $8.38 +0.01 (0.12%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
NA
Time: -- |
12/2022 | $-0.36 | 0.00% |
Earnings Summary
For their last quarter, Montes Archimedes Acquisition (ROIV) reported earnings of -$0.42 per share, missing the Zacks Consensus Estimate of -$0.41 per share. This reflects a negative earnings surprise of 2.44%. Look out for ROIV's next earnings release expected on . For the next earning release, we expect the company to report earnings of -$0.36 per share, reflecting a year-over-year increase of 12.2%.
Earnings History
Price & Consensus
Zacks News for ROIV
Pharma Stock Roundup: PFE & AZN Ink New M&A Deals, LLY Meets Alzheimer's Study Goal
ROIV: What are Zacks experts saying now?
Zacks Private Portfolio Services